Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Radiopharmaceuticals for Therapeutic Market Growth (Status and Outlook) 2022-2028

  • LP 4894289
  • 101 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Radiopharmaceuticals for Therapeutic will have significant change from previous year. According to our (LP Information) latest study, the global Radiopharmaceuticals for Therapeutic market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Radiopharmaceuticals for Therapeutic market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Radiopharmaceuticals for Therapeutic market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Radiopharmaceuticals for Therapeutic market, reaching US$ million by the year 2028. As for the Europe Radiopharmaceuticals for Therapeutic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Radiopharmaceuticals for Therapeutic players cover Bayer, Novartis, China Isotope & Radiation, and Dongcheng, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals for Therapeutic market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Radium-223

Lutetium-177

Iodine-131

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Thyroid

Bone Metastasis

Lymphoma

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Bayer

Novartis

China Isotope & Radiation

Dongcheng

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Lantheus

Spectrum Pharmaceuticals

Progenics Pharmaceuticals

International Isotopes

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Radiopharmaceuticals for Therapeutic Market Size 2017-2028

2.1.2 Radiopharmaceuticals for Therapeutic Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Radiopharmaceuticals for Therapeutic Segment by Type

2.2.1 Radium-223

2.2.2 Lutetium-177

2.2.3 Iodine-131

2.2.4 Other

2.3 Radiopharmaceuticals for Therapeutic Market Size by Type

2.3.1 Radiopharmaceuticals for Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)

2.4 Radiopharmaceuticals for Therapeutic Segment by Application

2.4.1 Thyroid

2.4.2 Bone Metastasis

2.4.3 Lymphoma

2.4.4 Other

2.5 Radiopharmaceuticals for Therapeutic Market Size by Application

2.5.1 Radiopharmaceuticals for Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)

3 Radiopharmaceuticals for Therapeutic Market Size by Player

3.1 Radiopharmaceuticals for Therapeutic Market Size Market Share by Players

3.1.1 Global Radiopharmaceuticals for Therapeutic Revenue by Players (2020-2022)

3.1.2 Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Players (2020-2022)

3.2 Global Radiopharmaceuticals for Therapeutic Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Radiopharmaceuticals for Therapeutic by Regions

4.1 Radiopharmaceuticals for Therapeutic Market Size by Regions (2017-2022)

4.2 Americas Radiopharmaceuticals for Therapeutic Market Size Growth (2017-2022)

4.3 APAC Radiopharmaceuticals for Therapeutic Market Size Growth (2017-2022)

4.4 Europe Radiopharmaceuticals for Therapeutic Market Size Growth (2017-2022)

4.5 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Growth (2017-2022)

5 Americas

5.1 Americas Radiopharmaceuticals for Therapeutic Market Size by Country (2017-2022)

5.2 Americas Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022)

5.3 Americas Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Radiopharmaceuticals for Therapeutic Market Size by Region (2017-2022)

6.2 APAC Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022)

6.3 APAC Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Radiopharmaceuticals for Therapeutic by Country (2017-2022)

7.2 Europe Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022)

7.3 Europe Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Radiopharmaceuticals for Therapeutic by Region (2017-2022)

8.2 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022)

8.3 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Radiopharmaceuticals for Therapeutic Market Forecast

10.1 Global Radiopharmaceuticals for Therapeutic Forecast by Regions (2023-2028)

10.1.1 Global Radiopharmaceuticals for Therapeutic Forecast by Regions (2023-2028)

10.1.2 Americas Radiopharmaceuticals for Therapeutic Forecast

10.1.3 APAC Radiopharmaceuticals for Therapeutic Forecast

10.1.4 Europe Radiopharmaceuticals for Therapeutic Forecast

10.1.5 Middle East & Africa Radiopharmaceuticals for Therapeutic Forecast

10.2 Americas Radiopharmaceuticals for Therapeutic Forecast by Country (2023-2028)

10.2.1 United States Radiopharmaceuticals for Therapeutic Market Forecast

10.2.2 Canada Radiopharmaceuticals for Therapeutic Market Forecast

10.2.3 Mexico Radiopharmaceuticals for Therapeutic Market Forecast

10.2.4 Brazil Radiopharmaceuticals for Therapeutic Market Forecast

10.3 APAC Radiopharmaceuticals for Therapeutic Forecast by Region (2023-2028)

10.3.1 China Radiopharmaceuticals for Therapeutic Market Forecast

10.3.2 Japan Radiopharmaceuticals for Therapeutic Market Forecast

10.3.3 Korea Radiopharmaceuticals for Therapeutic Market Forecast

10.3.4 Southeast Asia Radiopharmaceuticals for Therapeutic Market Forecast

10.3.5 India Radiopharmaceuticals for Therapeutic Market Forecast

10.3.6 Australia Radiopharmaceuticals for Therapeutic Market Forecast

10.4 Europe Radiopharmaceuticals for Therapeutic Forecast by Country (2023-2028)

10.4.1 Germany Radiopharmaceuticals for Therapeutic Market Forecast

10.4.2 France Radiopharmaceuticals for Therapeutic Market Forecast

10.4.3 UK Radiopharmaceuticals for Therapeutic Market Forecast

10.4.4 Italy Radiopharmaceuticals for Therapeutic Market Forecast

10.4.5 Russia Radiopharmaceuticals for Therapeutic Market Forecast

10.5 Middle East & Africa Radiopharmaceuticals for Therapeutic Forecast by Region (2023-2028)

10.5.1 Egypt Radiopharmaceuticals for Therapeutic Market Forecast

10.5.2 South Africa Radiopharmaceuticals for Therapeutic Market Forecast

10.5.3 Israel Radiopharmaceuticals for Therapeutic Market Forecast

10.5.4 Turkey Radiopharmaceuticals for Therapeutic Market Forecast

10.5.5 GCC Countries Radiopharmaceuticals for Therapeutic Market Forecast

10.6 Global Radiopharmaceuticals for Therapeutic Forecast by Type (2023-2028)

10.7 Global Radiopharmaceuticals for Therapeutic Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Bayer

11.1.1 Bayer Company Information

11.1.2 Bayer Radiopharmaceuticals for Therapeutic Product Offered

11.1.3 Bayer Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Bayer Main Business Overview

11.1.5 Bayer Latest Developments

11.2 Novartis

11.2.1 Novartis Company Information

11.2.2 Novartis Radiopharmaceuticals for Therapeutic Product Offered

11.2.3 Novartis Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis Main Business Overview

11.2.5 Novartis Latest Developments

11.3 China Isotope & Radiation

11.3.1 China Isotope & Radiation Company Information

11.3.2 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product Offered

11.3.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 China Isotope & Radiation Main Business Overview

11.3.5 China Isotope & Radiation Latest Developments

11.4 Dongcheng

11.4.1 Dongcheng Company Information

11.4.2 Dongcheng Radiopharmaceuticals for Therapeutic Product Offered

11.4.3 Dongcheng Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Dongcheng Main Business Overview

11.4.5 Dongcheng Latest Developments

11.5 Q BioMed

11.5.1 Q BioMed Company Information

11.5.2 Q BioMed Radiopharmaceuticals for Therapeutic Product Offered

11.5.3 Q BioMed Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Q BioMed Main Business Overview

11.5.5 Q BioMed Latest Developments

11.6 Curium Pharmaceuticals

11.6.1 Curium Pharmaceuticals Company Information

11.6.2 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered

11.6.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Curium Pharmaceuticals Main Business Overview

11.6.5 Curium Pharmaceuticals Latest Developments

11.7 Jubilant DraxImage

11.7.1 Jubilant DraxImage Company Information

11.7.2 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Product Offered

11.7.3 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Jubilant DraxImage Main Business Overview

11.7.5 Jubilant DraxImage Latest Developments

11.8 Lantheus

11.8.1 Lantheus Company Information

11.8.2 Lantheus Radiopharmaceuticals for Therapeutic Product Offered

11.8.3 Lantheus Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Lantheus Main Business Overview

11.8.5 Lantheus Latest Developments

11.9 Spectrum Pharmaceuticals

11.9.1 Spectrum Pharmaceuticals Company Information

11.9.2 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered

11.9.3 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Spectrum Pharmaceuticals Main Business Overview

11.9.5 Spectrum Pharmaceuticals Latest Developments

11.10 Progenics Pharmaceuticals

11.10.1 Progenics Pharmaceuticals Company Information

11.10.2 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered

11.10.3 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Progenics Pharmaceuticals Main Business Overview

11.10.5 Progenics Pharmaceuticals Latest Developments

11.11 International Isotopes

11.11.1 International Isotopes Company Information

11.11.2 International Isotopes Radiopharmaceuticals for Therapeutic Product Offered

11.11.3 International Isotopes Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 International Isotopes Main Business Overview

11.11.5 International Isotopes Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Radiopharmaceuticals for Therapeutic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Radium-223

Table 3. Major Players of Lutetium-177

Table 4. Major Players of Iodine-131

Table 5. Major Players of Other

Table 6. Radiopharmaceuticals for Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)

Table 9. Radiopharmaceuticals for Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)

Table 12. Global Radiopharmaceuticals for Therapeutic Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Player (2020-2022)

Table 14. Radiopharmaceuticals for Therapeutic Key Players Head office and Products Offered

Table 15. Radiopharmaceuticals for Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Radiopharmaceuticals for Therapeutic Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Regions (2017-2022)

Table 20. Americas Radiopharmaceuticals for Therapeutic Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Radiopharmaceuticals for Therapeutic Market Size Market Share by Country (2017-2022)

Table 22. Americas Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)

Table 24. Americas Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)

Table 26. APAC Radiopharmaceuticals for Therapeutic Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Radiopharmaceuticals for Therapeutic Market Size Market Share by Region (2017-2022)

Table 28. APAC Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)

Table 30. APAC Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)

Table 32. Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Country (2017-2022)

Table 34. Europe Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)

Table 36. Europe Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Radiopharmaceuticals for Therapeutic

Table 45. Key Market Challenges & Risks of Radiopharmaceuticals for Therapeutic

Table 46. Key Industry Trends of Radiopharmaceuticals for Therapeutic

Table 47. Global Radiopharmaceuticals for Therapeutic Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Radiopharmaceuticals for Therapeutic Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Radiopharmaceuticals for Therapeutic Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Radiopharmaceuticals for Therapeutic Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Radiopharmaceuticals for Therapeutic Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Radiopharmaceuticals for Therapeutic Market Size Market Share Forecast by Application (2023-2028)

Table 53. Bayer Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 54. Bayer Radiopharmaceuticals for Therapeutic Product Offered

Table 55. Bayer Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Bayer Main Business

Table 57. Bayer Latest Developments

Table 58. Novartis Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 59. Novartis Radiopharmaceuticals for Therapeutic Product Offered

Table 60. Novartis Main Business

Table 61. Novartis Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Novartis Latest Developments

Table 63. China Isotope & Radiation Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 64. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product Offered

Table 65. China Isotope & Radiation Main Business

Table 66. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. China Isotope & Radiation Latest Developments

Table 68. Dongcheng Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 69. Dongcheng Radiopharmaceuticals for Therapeutic Product Offered

Table 70. Dongcheng Main Business

Table 71. Dongcheng Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Dongcheng Latest Developments

Table 73. Q BioMed Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 74. Q BioMed Radiopharmaceuticals for Therapeutic Product Offered

Table 75. Q BioMed Main Business

Table 76. Q BioMed Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Q BioMed Latest Developments

Table 78. Curium Pharmaceuticals Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 79. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered

Table 80. Curium Pharmaceuticals Main Business

Table 81. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Curium Pharmaceuticals Latest Developments

Table 83. Jubilant DraxImage Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 84. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Product Offered

Table 85. Jubilant DraxImage Main Business

Table 86. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Jubilant DraxImage Latest Developments

Table 88. Lantheus Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 89. Lantheus Radiopharmaceuticals for Therapeutic Product Offered

Table 90. Lantheus Main Business

Table 91. Lantheus Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Lantheus Latest Developments

Table 93. Spectrum Pharmaceuticals Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 94. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered

Table 95. Spectrum Pharmaceuticals Main Business

Table 96. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Spectrum Pharmaceuticals Latest Developments

Table 98. Progenics Pharmaceuticals Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 99. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered

Table 100. Progenics Pharmaceuticals Main Business

Table 101. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Progenics Pharmaceuticals Latest Developments

Table 103. International Isotopes Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors

Table 104. International Isotopes Radiopharmaceuticals for Therapeutic Product Offered

Table 105. International Isotopes Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. International Isotopes Main Business

Table 107. International Isotopes Latest Developments

List of Figures

Figure 1. Radiopharmaceuticals for Therapeutic Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Type in 2021

Figure 7. Radiopharmaceuticals for Therapeutic in Thyroid

Figure 8. Global Radiopharmaceuticals for Therapeutic Market: Thyroid (2017-2022) & ($ Millions)

Figure 9. Radiopharmaceuticals for Therapeutic in Bone Metastasis

Figure 10. Global Radiopharmaceuticals for Therapeutic Market: Bone Metastasis (2017-2022) & ($ Millions)

Figure 11. Radiopharmaceuticals for Therapeutic in Lymphoma

Figure 12. Global Radiopharmaceuticals for Therapeutic Market: Lymphoma (2017-2022) & ($ Millions)

Figure 13. Radiopharmaceuticals for Therapeutic in Other

Figure 14. Global Radiopharmaceuticals for Therapeutic Market: Other (2017-2022) & ($ Millions)

Figure 15. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2021

Figure 16. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Player in 2021

Figure 17. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Radiopharmaceuticals for Therapeutic Market Size 2017-2022 ($ Millions)

Figure 19. APAC Radiopharmaceuticals for Therapeutic Market Size 2017-2022 ($ Millions)

Figure 20. Europe Radiopharmaceuticals for Therapeutic Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size 2017-2022 ($ Millions)

Figure 22. Americas Radiopharmaceuticals for Therapeutic Value Market Share by Country in 2021

Figure 23. Americas Radiopharmaceuticals for Therapeutic Consumption Market Share by Type in 2021

Figure 24. Americas Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2021

Figure 25. United States Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Radiopharmaceuticals for Therapeutic Market Size Market Share by Region in 2021

Figure 30. APAC Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2021

Figure 31. China Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Country in 2021

Figure 38. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Type in 2021

Figure 39. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2021

Figure 40. Germany Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2021

Figure 48. Egypt Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 54. APAC Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 55. Europe Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 57. United States Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 58. Canada Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 61. China Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 62. Japan Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 63. Korea Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 65. India Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 66. Australia Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 67. Germany Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 68. France Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 69. UK Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 70. Italy Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 71. Russia Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 72. Spain Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 75. Israel Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390